Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Dale Baker who wrote (1325)	6/15/1999 11:26:00 AM
From: Jim Roof	Read Replies (2) \| Respond to of 1432

Au contrare. All the info is not on the table. Sales figures are certainly not known. The short interest is banking on weak sales and, at the onset of marketing, they will surely trumpet the fact that in the first month of availability there is weakness... as there would be for any new product just hitting the market. Other unknowns include a final deal with Nihon (letter of intent signed long ago) and possible deals in Europe. I think there are many cards yet to be played. Jim